plutonium has been researched along with Acute Myelogenous Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ellender, M; Harrison, JD; Pottinger, H; Thomas, JM | 1 |
| Austin, AL; Ellender, M; Haines, JW; Harrison, JD; Lord, BI | 1 |
2 other study(ies) available for plutonium and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Induction of osteosarcoma and acute myeloid leukaemia in CBA/H mice by the alpha-emitting nuclides, uranium-233, plutonium-239 and amercium-241.
Topics: Americium; Animals; Bone and Bones; Dose-Response Relationship, Radiation; Female; Leukemia, Myeloid, Acute; Male; Mice; Mice, Inbred CBA; Neoplasms, Radiation-Induced; Osteosarcoma; Plutonium; Radioisotopes; Regression Analysis; Time Factors; Tissue Distribution; Uranium | 2001 |
Tumorigenic target cell regions in bone marrow studied by localized dosimetry of 239Pu, 241Am and 233U in the mouse femur.
Topics: Americium; Animals; Autoradiography; Bone Marrow; Dose-Response Relationship, Radiation; Femur; Humans; Leukemia, Myeloid, Acute; Male; Mice; Mice, Inbred CBA; Neoplasms, Radiation-Induced; Osteosarcoma; Plutonium; Radiometry; Risk Factors; Tissue Distribution; Uranium | 2001 |